Skip to main navigation Skip to search Skip to main content

Cardiac septal defects: Treatment via the Amplatzer® family of devices

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The majority of patients with congenital heart disease present with defects resulting from vascular narrowing or absence (such as interruption or coarctation of the aorta or pulmonary arteries) or failure of structures to fuse or separate during development (total anomalous pulmonary venous connection, septal defects, fusion of valve cusps). Corrections of these defects initially began with open-heart surgery but now many of these repairs can be performed through catheter-delivered closure devices (e.g., Amplatzer closure devices). This chapter will present a brief history of defect repairs and provide information on the designs, developments, and preclinical animal testing of such systems.

Original languageEnglish (US)
Title of host publicationHandbook of Cardiac Anatomy, Physiology, and Devices
Subtitle of host publicationFourth Edition
PublisherSpringer Nature
Pages835-849
Number of pages15
ISBN (Electronic)9783031725814
ISBN (Print)9783031725807
DOIs
StatePublished - Dec 8 2024

Bibliographical note

Publisher Copyright:
© The Author(s), 2024. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atrial septal defect
  • Interventional cardiac catheterization
  • Muscular ventricular septal defect
  • Patent ductus arteriosus
  • Perimembranous ventricular septal defect
  • Transcatheter closure

Fingerprint

Dive into the research topics of 'Cardiac septal defects: Treatment via the Amplatzer® family of devices'. Together they form a unique fingerprint.

Cite this